Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
BMC Ophthalmology
|
December 23, 2009
Evaluation of a new disposable silicon limbal relaxing incision knife by experienced users
John Albanese, Geoffrey Dugue, Valentin Parvu, et al.
Gynecologic Oncology
|
May 7, 2023
Risk stratification of HPV-positive results using extended genotyping and cytology: Data from the baseline phase of the Onclarity trial
Mark H Stoler, Valentin Parvu, Karen Yanson, et al.
Microbiology Spectrum
|
September 12, 2025
Improved time-to-detection with the new formulation of BD BACTEC Plus Aerobic/F Culture Vials: a real-world evidence study
Kayla Van Benten, Mondraya Howard, Valentin Parvu, et al.
Journal of Biopharmaceutical Statistics
|
June 1, 2022
A pragmatic approach for dynamically incorporating predicate device data in prospective diagnostic test studies
Graeme L Hickey, Valentin Parvu, Yongqiang Zhang, et al.
Gynecologic Oncology Reports
|
June 17, 2024
Variables that impact HPV test accuracy during vaginal self collection workflow for cervical cancer screening
Laurence Vaughan, Devin Gary, Millie Shah, et al.
Journal of Clinical Microbiology
|
September 5, 2025
Enhancing blood culture volume with ultrathin-wall cannula devices
Grant Johnson, Valentin Parvu, Stephane Beauchamp, et al.
Gynecologic Oncology
|
June 5, 2019
Risk detection for high-grade cervical disease using Onclarity HPV extended genotyping in women, ≥21 years of age, with ASC-US or LSIL cytology
Thomas C Wright, Mark H Stoler, Valentin Parvu, et al.
Frontiers in Public Health
|
April 22, 2022
Large-Scale SARS-CoV-2 Antigen Testing With Real-World Specimens
Ashish Parikh, Lauren Cooper, Daniel Frogel, et al.
Gynecologic Oncology
|
March 5, 2026
HPV genotype prevalence in low- and high-vaccine coverage, USA populations: Data from real-world cervical cancer screening using the Onclarity HPV assay
Didier Morel, Valentin Parvu, Jeffrey Andrews, et al.
Gynecologic Oncology
|
January 15, 2019
Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, ≥25 years of age, with NILM cytology
Mark H Stoler, Thomas C Wright, Valentin Parvu, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
BMC Ophthalmology
|
December 23, 2009
Evaluation of a new disposable silicon limbal relaxing incision knife by experienced users
John Albanese, Geoffrey Dugue, Valentin Parvu, et al.
Gynecologic Oncology
|
May 7, 2023
Risk stratification of HPV-positive results using extended genotyping and cytology: Data from the baseline phase of the Onclarity trial
Mark H Stoler, Valentin Parvu, Karen Yanson, et al.
Microbiology Spectrum
|
September 12, 2025
Improved time-to-detection with the new formulation of BD BACTEC Plus Aerobic/F Culture Vials: a real-world evidence study
Kayla Van Benten, Mondraya Howard, Valentin Parvu, et al.
Journal of Biopharmaceutical Statistics
|
June 1, 2022
A pragmatic approach for dynamically incorporating predicate device data in prospective diagnostic test studies
Graeme L Hickey, Valentin Parvu, Yongqiang Zhang, et al.
Gynecologic Oncology Reports
|
June 17, 2024
Variables that impact HPV test accuracy during vaginal self collection workflow for cervical cancer screening
Laurence Vaughan, Devin Gary, Millie Shah, et al.
Journal of Clinical Microbiology
|
September 5, 2025
Enhancing blood culture volume with ultrathin-wall cannula devices
Grant Johnson, Valentin Parvu, Stephane Beauchamp, et al.
Gynecologic Oncology
|
June 5, 2019
Risk detection for high-grade cervical disease using Onclarity HPV extended genotyping in women, ≥21 years of age, with ASC-US or LSIL cytology
Thomas C Wright, Mark H Stoler, Valentin Parvu, et al.
Frontiers in Public Health
|
April 22, 2022
Large-Scale SARS-CoV-2 Antigen Testing With Real-World Specimens
Ashish Parikh, Lauren Cooper, Daniel Frogel, et al.
Gynecologic Oncology
|
March 5, 2026
HPV genotype prevalence in low- and high-vaccine coverage, USA populations: Data from real-world cervical cancer screening using the Onclarity HPV assay
Didier Morel, Valentin Parvu, Jeffrey Andrews, et al.
Gynecologic Oncology
|
January 15, 2019
Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, ≥25 years of age, with NILM cytology
Mark H Stoler, Thomas C Wright, Valentin Parvu, et al.
Page
of 3